These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3335027

  • 1. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia.
    Watanabe N, Niitsu Y, Umeno H, Sone H, Neda H, Yamauchi N, Maeda M, Urushizaki I.
    Cancer Res; 1988 Feb 01; 48(3):650-3. PubMed ID: 3335027
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis.
    Niitsu Y, Watanabe N, Umeno H, Sone H, Neda H, Yamauchi N, Maeda M, Urushizaki I.
    Cancer Res; 1988 Feb 01; 48(3):654-7. PubMed ID: 2825981
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
    Watanabe N, Niitsu Y, Yamauchi N, Ohtsuka Y, Sone H, Neda H, Maeda M, Urushizaki I.
    Immunopharmacol Immunotoxicol; 1988 Feb 01; 10(1):117-27. PubMed ID: 2452179
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro studies of the potentiation of tumor necrosis factor (TNF)-alpha, TNF-beta, and TNF-SAM2 cytotoxicity by hyperthermia.
    Tomasovic SP, Lu S, Klostergaard J.
    J Immunother (1991); 1992 Feb 01; 11(2):85-92. PubMed ID: 1571335
    [Abstract] [Full Text] [Related]

  • 7. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT.
    Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671
    [Abstract] [Full Text] [Related]

  • 8. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
    Baisch H, Otto U, Klöppel G.
    Cancer Res; 1990 Oct 01; 50(19):6389-95. PubMed ID: 2400997
    [Abstract] [Full Text] [Related]

  • 9. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A, Rommel F, Breise M, Willers R, Göbel U, Wessalowski R.
    Klin Padiatr; 2002 Oct 01; 214(4):223-9. PubMed ID: 12165906
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapy.
    Haranaka K, Sakurai A, Satomi N.
    J Biol Response Mod; 1987 Aug 01; 6(4):379-91. PubMed ID: 3625230
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T, Shimomura K, Mukumoto S, Kobayashi K, Mizota T, Hirai O, Matsumoto S, Oku T, Nishigaki F, Mori J.
    Cancer Res; 1987 Jul 15; 47(14):3707-11. PubMed ID: 3594435
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. TNF receptor number-dependent cytotoxicity to TNF-resistant human esophageal cancer cell lines by combination with recombinant human necrosis factor and hyperthermia.
    Saito T, Kato H, Saito M, Karaki Y, Tazawa K, Fujimaki M.
    Hum Cell; 1994 Mar 15; 7(1):55-61. PubMed ID: 8025021
    [Abstract] [Full Text] [Related]

  • 16. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.
    Creasey AA, Reynolds MT, Laird W.
    Cancer Res; 1986 Nov 15; 46(11):5687-90. PubMed ID: 3756916
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F, Stuart OA, Glehen O, Urano M, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2006 Dec 15; 58(6):719-24. PubMed ID: 16614851
    [Abstract] [Full Text] [Related]

  • 19. Combined modality therapy with bleomycin, hyperthermia, and radiation.
    Teicher BA, Herman TS, Holden SA.
    Cancer Res; 1988 Nov 15; 48(22):6291-7. PubMed ID: 2460220
    [Abstract] [Full Text] [Related]

  • 20. Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine cells and the murine FSaIIC fibrosarcoma.
    Herman TS, Teicher BA, Pfeffer MR, Khandekar VS, Korbut TT.
    Cancer Res; 1990 Jul 01; 50(13):3826-31. PubMed ID: 2354434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.